The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
Washington — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...
Kennedy has become a powerful voice advocating for the removal of artificial dyes and chemicals that he says are “poisoning” ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...